Key Highlights
- First government‑run AI‑based program worldwide for glaucoma, diabetic retinopathy and age‑related macular degeneration detection.
- Remidio’s AI‑enabled fundus cameras classify patients instantly as referable or non‑referable.
- Screening network expanded from Family Health Centres to Community Health Centres, Taluk Hospitals and District Hospitals.
- AI assists optometrists, freeing ophthalmologists to manage complex cases, thus increasing system efficiency.
- Goal: lower preventable blindness by catching high‑risk eyes early and routing them to specialist care.
Detailed Insights
The original Nayanamritham scheme confined its scope to diabetic‑retinopathy checks at Family Health Centres (FHCs). Suspected cases were sent onward to higher‑level hospitals for specialist review. Building on that foundation, Nayanamritham 2.0 incorporates Remidio’s deep‑learning algorithms that evaluate fundus images for three chronic eye disorders: diabetic retinopathy, open‑angle glaucoma and age‑related macular degeneration. The cameras transmit the image to a cloud‑hosted model, which then returns a binary decision—referable or non‑referable—within seconds. This rapid triage shortens patient wait times and reduces the burden on tertiary ophthalmology units.
Geographically, the programme now operates at multiple tiers of the public health hierarchy: Community Health Centres (CHCs), Taluk Hospitals and District Hospitals, in addition to the existing FHCs. By embedding the AI workflow into the routine patient pathway, the state can screen a far larger demographic without proportionally increasing staff numbers or costs. According to Remidio’s CEO Anand Sivaraman, the collaboration demonstrates how public‑sector procurement can accelerate deployment of cutting‑edge diagnostics at scale.
Clinicians such as Dr. Bipin Gopal stress that AI is a decision‑support tool rather than a replacement for human expertise. Optometrists use the AI‑enabled devices for routine case‑finding, while ophthalmologists focus on surgical or pharmacologic interventions for the subset flagged as high‑risk. This division of labour optimises resource allocation and is being cited as a model for other Indian states and low‑ and middle‑income nations seeking to curb avoidable sight loss.
Key Concepts
- AI‑Powered Fundus Camera: A retinal imaging device coupled with a deep‑learning algorithm that automatically interprets vascular and structural features to detect disease.
- Referable vs. Non‑Referable: Binary categorisation indicating whether a patient needs further specialist evaluation (referable) or can be safely monitored without immediate referral (non‑referable).
- Diabetic Retinopathy (DR): Microvascular damage to the retina caused by prolonged hyperglycemia, leading to vision loss if untreated.
- Glaucoma: Progressive optic‑nerve degeneration often associated with elevated intra‑ocular pressure, resulting in irreversible visual field loss.
- Age‑Related Macular Degeneration (AMD): Degenerative condition of the macula that impairs central vision, prevalent in older adults.